Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: September 30, 2019

¨	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

FOR THE TRANSITION PERIOD FROM __________ TO __________

COMMISSION FILE NUMBER 000-55661

EOS Inc.

(Exact name of registrant as specified in its charter)

Nevada

30-0873246

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer

Identification No.)

7F.-1, No. 162, Sec. 2, Zhongshan N. Rd., Zhongshan District

Taipei City 10452, Taiwan

(Address of principal executive offices, Zip Code)

+886-2-2586-8300

(Registrant’s telephone number, including area code)

_____________________________________________

(Former name or former address, if changed since last report)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x	Smaller reporting company	x
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of registrant’s common stock outstanding, as of November 13, 2019 is 74,122,997.

Securities registered pursuant to Section 12(b) of the Act: None.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements	F-2

	Consolidated Balance Sheets	F-2

	Consolidated Statements of Operations and Comprehensive Income (Loss)	F-3

	Consolidated Statements of Stockholders’ Equity	F-4

	Consolidated Statements of Cash Flows	F-5

	Notes to Consolidated Financial Statements	F-6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	3
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14
Item 4.	Controls and Procedures	14

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	15
Item 1A.	Risk Factors	15
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3.	Defaults Upon Senior Securities	15
Item 4.	Mine Safety Disclosures	15
Item 5.	Other Information	15
Item 6.	Exhibits	15

SIGNATURES		16

FINANCIAL STATEMENT SCHEDULES

Financial Statements:

Consolidated Balance Sheets		F-2

Consolidated Statements of Operations and Comprehensive Income (Loss)		F-3

Consolidated Statements of Stockholders’ Equity		F-4

Consolidated Statements of Cash Flows		F-5

Notes to Consolidated Financial Statements		F-6

F-1

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

EOS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	September 30,			December 31,
	2019			2018
	(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$	12,018		$	36,130
Accounts receivable		1,689,813			464,937
Accounts receivable – related parties		-			1,365,321
Inventory, net		419			7,211
Advance to suppliers		30,858			25,879
Prepaid expenses and other current assets		7,792			28,060
Total current assets		1,740,900			1,927,538

Property and equipment, net		7,089			7,650
Operating lease right-of-use assets		39,226			-
Security deposit		6,840			2,693
Long-term investment		27,221			-
Total Assets	$	1,821,276		$	1,937,881

Liabilities and Stockholders’ Equity

Current Liabilities
Accounts payable	$	3,535		$	46,400
Accrued expenses		52,897			66,466
Due to shareholders		153,805			147,281
Income tax payable		24,909			38,945
Operating lease liabilities – current		22,351			-
Total current liabilities		257,497			299,092

Operating lease liabilities – noncurrent		16,876			-
Total liabilities		274,373			299,092

Stockholders’ Equity
Common stock, $0.001 par value;
75,000,000 shares authorized, 74,122,997 shares and 64,122,997 issued and outstanding, respectively		74,123			64,123
Additional paid-in capital		112,425			90,000
Retained earnings		1,384,277			1,496,131
Accumulated other comprehensive income (loss)		(23,922	)		(11,465	)
Total stockholders’ equity		1,546,903			1,638,789

Total Liabilities and Stockholders’ Equity	$	1,821,276		$	1,937,881

The accompanying notes are an integral part of these consolidated financial statements.

F-2

Table of Contents

EOS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

	For the Nine Months Ended September 30,						For the Three Months Ended September 30,
	2019			2018			2019			2018
Net sales	$	628,864		$	770,432		$	390,692		$	345,260

Cost of sales		101,357			94,708			56,536			43,308

Gross profit		527,507			675,724			334,156			301,952

Selling, general and administrative expenses		648,798			370,929			274,868			107,633

Income (loss) from operations		(121,291	)		304,795			59,288			194,319

Other income (expense)
Interest income		48			40			-			1
Other income (expense)		12			2,029			12			(3	)
Gain (loss) on foreign currency exchange		14,582			25,656			2,057			(3,267	)
Gain (loss) on investment in equity securities		(5,205	)		-			(2,779	)		-
Total other income (expense)		9,437			27,725			(710	)		(3,269	)

Income (loss) before income tax provision		(111,854	)		332,520			58,578			191,050

Income tax provision		-			25,295			-			-

Net income (loss)	$	(111,854	)	$	307,225		$	58,578		$	191,050

Other Comprehensive Income (Loss):
Net income (loss)	$	(111,854	)	$	307,225		$	58,578		$	191,050
Foreign currency translation adjustment, net of tax		(12,457	)		(21,794	)		(3,514	)		(787	)
Comprehensive Income (Loss)	$	(124,311	)	$	285,431		$	55,064		$	190,263

Net income (loss) per share:
Basic and diluted	$	(0.00	)	$	0.00		$	0.00		$	0.00

Weighted average number of common shares:
Basic and diluted		68,848,272			64,122,997			74,122,997			64,122,997

The accompanying notes are an integral part of these consolidated financial statements.

F-3

Table of Contents

EOS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(UNAUDITED)

					Additional					Other
	Common Stock				Paid-in		Retained			Comprehensive
	Shares		Amount		Capital		Earnings			Income (Loss)			Total
Balance at December 31, 2018		64,122,997	$	64,123	$	90,000	$	1,496,131		$	(11,465	)	$	1,638,789
Foreign currency translation adjustment		-		-		-		-			(7,090	)		(7,090	)
Net income (loss)		-		-		-		(16,972	)		-			(16,972	)
Balance at March 31, 2019		64,122,997	$	64,123	$	90,000	$	1,479,159		$	(18,555	)	$	1,614,727
Common shares issued in exchange
for investment in equity securities		10,000,000		10,000		22,425		-			-			32,425
Foreign currency translation adjustment		-		-		-		-			(1,853	)		(1,853	)
Net income (loss)		-		-		-		(153,460	)		-			(153,460	)
Balance at June 30, 2019		74,122,997	$	74,123	$	112,425	$	1,325,699		$	(20,408	)	$	1,491,839
Foreign currency translation adjustment		-		-		-		-			(3,514	)		(3,514	)
Net income (loss)		-		-		-		58,578			-			58,578
Balance at September 30, 2019		74,122,997	$	74,123	$	112,425	$	1,384,277		$	(23,922	)	$	1,546,903

										Accumulated
					Additional					Other
	Common Stock				Paid-in		Retained			Comprehensive
	Shares		Amount		Capital		Earnings			Income (Loss)			Total
Balance at December 31, 2017		64,122,997	$	64,123	$	90,000	$	466,806		$	12,554		$	633,483
Foreign currency translation adjustment		-		-		-		-			11,661			11,661
Net Income (Loss)		-		-		-		(61,858	)		-			(61,858	)
Balance at March 31, 2018		64,122,997	$	64,123	$	90,000	$	404,948		$	24,215		$	583,286
Foreign currency translation adjustment		-		-		-		-			(32,668	)		(32,668	)
Net Income (Loss)		-		-		-		178,033			-			178,033
Balance at June 30, 2018		64,122,997	$	64,123	$	90,000	$	582,981		$	(8,453	)	$	728,651
Foreign currency translation adjustment		-		-		-		-			(787	)		(787	)
Net Income (Loss)		-		-		-		191,050			-			191,050
Balance at September 30, 2018		64,122,997	$	64,123	$	90,000	$	774,031		$	(9,240	)	$	918,914

The accompanying notes are an integral part of these consolidated financial statements.

F-4

Table of Contents

EOS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Nine Months Ended September 30,
	2019			2018
Cash Flows from Operating Activities
Net income (loss)	$	(111,854	)	$	307,225
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Depreciation		1,384			1,931
Loss on investment in equity securities		5,205			-
(Gain) loss on foreign currency exchange		(14,582	)		(25,656	)
Changes in assets and liabilities:
Decrease (increase) in accounts receivable		139,635			(281,481	)
Decrease (increase) in inventory		2,502			(25,948	)
Decrease (increase) in advance to suppliers		(5,351	)		(20,642	)
Decrease (increase) in prepaid expense and other assets		19,864			9,447
Increase (decrease) in accounts payable		(42,865	)		(34,095	)
Increase (decrease) in accrued expenses		(12,789	)		8,956
Increase (decrease) in income tax payable		(13,477	)		12,297
Increase (decrease) in due to shareholders		8,328			84,243
Net cash provided by (used in) operating activities		(24,000	)		36,277

Cash flows from investing activities
Purchase of equipment		(933	)		(2,890	)
Net cash used in investing activities		(933	)		(2,890	)

Effect of exchange rate changes on cash and cash equivalents		821			(152	)
Net increase (decrease) in cash and cash equivalents		(24,112	)		33,235

Cash and Cash Equivalents
Beginning		36,130			24,610
Ending	$	12,018		$	57,845
Supplemental Disclosure of Cash Flows
Cash paid during the periods for:
Interest	$	-		$	-
Income taxes	$	8,125		$	12,998

Non-cash financing and investing activities
Common shares issued in exchange for investment in equity securities	$	32,425		$	-

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Table of Contents

EOS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDAED FINANCIAL STATEMENTS

SEPTEMBER 30, 2019

Note 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial reporting and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data were derived from audited consolidated financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited consolidated financial statements, footnote disclosures, and other information should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Organization

EOS Inc. was incorporated on April 3, 2015 in the State of Nevada. The Company’s business plan is to market and distribute skin care products, including masks and serums.

On November 18, 2016, the Company has set up a wholly-owned subsidiary in Taiwan to assist the Company to promote the business in Taiwan.

Emperor Star International Trade Co., Ltd., (“Emperor Star”), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifiers.

On May 3, 2017, the Company entered into and closed a Share Purchase and Sale Agreement (the “Purchase Agreement”) with Emperor Star and the shareholder of Emperor Star acquired all of the issued and outstanding shares of Emperor Star in consideration of $30,562 in cash. As a result of the Purchase, Emperor Star became the Company’s wholly owned subsidiary. Upon consummation of the transaction, the Company has assumed the business of Emperor Star and ceased to be a shell company.

On March 1, 2019, EOS(BVI) set up a wholly-owned subsidiary, Shanghai Maosong Co., Ltd (“Maosong”), under the laws of People’s Republic of China. Maosong is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifiers in China. As of the date of this report, Maosong has a registered capital of USD $100,000, but no capital has actually been paid into Maosong.

F-6

Table of Contents

Principles of Consolidation

The accompanying unaudited consolidated financial statements, including the accounts of EOS Inc. and its wholly owned subsidiaries in Taiwan, British Virgin Islands, and People’s Republic of China, have been prepared in conformity with accounting principles generally accepted in the United States of America. Since the Company and Emperor Star are entities under common control prior to the acquisition of Emperor Star, the transaction is accounted for as a restructuring transaction. All the assets and liabilities of Emperor Star were transferred to the Company at their respective carrying amounts on the date of transaction. The Company has recast prior period financial statements to reflect the conveyance of Emperor Star’s common shares as if the restructuring transaction had occurred as of the earliest date of the financial statements. All material intercompany accounts, transactions, and profits have been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of nonrecurring intra-entity transactions involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of the transferred net assets.

The functional currency of the subsidiaries in Taiwan is the New Taiwan dollars and the subsidiary in People’s Republic of China is the Chinese Yuan, or Renminbi; however, the accompanying unaudited consolidated financial statements have been translated and presented in United States Dollars ($). In the accompanying unaudited consolidated financial statements and notes, “$”, “US$” and “U.S. dollars” mean United States dollars, “NT$” and “NT dollars” mean New Taiwan dollars, and “RMB” means Chinese Yuan, or Renminbi.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Classification

Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net income nor retained earnings.

Cash and Cash Equivalents

Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.

Accounts Receivable

Accounts receivable are stated at carrying value less estimates made for doubtful receivables. An allowance for impairment of trade receivables is established if the collection of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate. An impairment loss is recognized in the statement of income, as are subsequent recoveries of previous impairments.

F-7

Table of Contents

Inventory

Inventory is stated at the lower of cost and net realizable value. Net realizable value (NRV) is defined as estimated selling prices less costs of completion, disposal, and transportation. Inventory consists mainly of finished goods held for resale. Cost is determined on a weighted average cost method. The Company periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence.

Property and Equipment

Property and equipment is carried at cost net of accumulated depreciation. Repairs and maintenance are expensed as incurred. Expenditures that improve the functionality of the related asset or extend the useful life are capitalized. When property and equipment is retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold improvements are depreciated on the straight-line method over the shorter of the remaining lease term or estimated useful life of the asset. Depreciation is calculated on the straight-line method, including property and equipment under capital leases, generally is five years. Depreciation expense is $1,384 and $1,931 for the nine months ended September 30, 2019 and 2018, respectively.

Impairment of Long-Lived Assets

The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long-lived assets for impairment annually or more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve breakeven operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Management has determined that no impairments of long-lived assets currently exist as of September 30, 2019 and December 31, 2018.

Long-term Equity Investment

The Company acquires equity investment to promote business and strategic objectives. The Company accounts for non-marketable equity and other equity investments for which the Company does not have control over the investees as:

·	Equity method investments when the Company has the ability to exercise significant influence, but not control, over the investee. Its proportionate share of the income or loss is recognized monthly and is recorded in gain (loss) on equity investments.

·	Non-marketable cost method investments when the equity method does not apply.

F-8

Table of Contents

Significant judgment is required to identify whether an impairment exists in the valuation of the Company’s non-marketable equity investments, and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative factors that may have a significant impact on the investee’s fair value. Qualitative analysis of its investments involves understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee’s industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair value of its investments are developed using the market and income approaches. The market approach includes the use of comparable financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding the investees’ revenue, costs, and discount rates. The Company’s assessment of these factors in determining whether an impairment exists could change in the future due to new developments or changes in applied assumptions.

Other-Than-Temporary Impairment

The Company’s long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:

·	Marketable equity securities include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. The Company also considers specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. The Company records other-than-temporary impairments on marketable equity securities and marketable equity method investments in gain (loss) on equity investments.

·	Non-marketable equity investments based on the Company’s assessment of the severity and duration of the impairment, and qualitative and quantitative analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory or economic environment; changes in operating structure or management of the investee; additional funding requirements; and the investee’s ability to remain in business. A series of operating losses of an investee or other factors may indicate that a decrease in value of the investment has occurred that is other than temporary and that shall be recognized even though the decrease in value is in excess of what would otherwise be recognized by application of the equity method. A loss in value of an investment that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company records other-than-temporary impairments for non-marketable cost method investments and equity method investments in gain (loss) on equity investments.

Revenue Recognition

During the fiscal year 2018, the Company has adopted FASB Accounting Standards Codification (“ASC”), Topic 606 (“ASC 606”), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were not completed as of January 1, 2018. The Company recognized the cumulative effect of applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at the beginning of 2018. The results for the Company’s reporting periods beginning on and after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for the prior period. Based on the Company’s review of existing sales contracts as of January 1, 2018, the Company concluded that the adoption of the new guidance did not have a significant change on the Company’s revenue during all periods presented.

F-9

Table of Contents

Pursuant to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Merchandise sales: The Company recognizes sales revenues from merchandise sales when customers obtain control of the Company’s products, which typically occurs upon delivery to customer. Merchandise sales revenues are recorded at the sales price, or “transaction price”.

Software sales: The Company does not develop the software products on its own. When the Company receives a purchase order from the customer, the Company would engage with the third-party software company to customize and develop the software products. The Company recognizes software revenues upon completion of the installation and testing, and transfer the control of the software products to the customer. Software revenues are recorded at the fixed sales price, or “transaction price”, pursuant to the sales contracts. The Company may also charge the customer maintenance service fees on a straight-line basis over the service period pursuant to the sales contract. The Company concluded that the performance obligation for the maintenance service is distinct. Therefore, such maintenance service revenue can be separated from other elements in the arrangement.

Trade discount and allowances: The Company generally does not provide invoice discounts on product sales to its customers for prompt payment.

Product returns: The Company generally does not provide customers with the right to return a product for a full or partial refund, a credit, or an exchange for another product.

To date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products will continue to be minimal.

The following tables provide details of revenue by major products and by geography.

Revenue by Major Products

For the nine months ended September 30, 2019:
Nutrition supplement	$	343,293
Skin care product		147,707
Water purifier machine		42,668
Software		95,196
Total	$	628,864

F-10

Table of Contents

Revenue by Geography

For the nine months ended September 30, 2019:
Asia Pacific	$	628,864
Total	$	628,864

Leases -— The Company adopted FASB Accounting Standards Codification, Topic 842, Leases (“ASC 842”) using the modified retrospective approach, electing the practical expedient that allows the Company not to restate its comparative periods prior to the adoption of the standard on January 1, 2019. As such, the disclosures required under ASC 842 are not presented for periods before the date of adoption. For the comparative periods prior to adoption, the Company presented the disclosures which were required under ASC 840.

The Company applied the following practical expedients in the transition to the new standard and allowed under ASC 842:

Practical Expedient	Description
Reassessment of expired or existing contracts	The Company elected not to reassess, at the application date, whether any expired or existing contracts contained leases, the lease classification for any expired or existing leases, and the accounting for initial direct costs for any existing leases.
Use of hindsight	The Company elected to use hindsight in determining the lease term (that is, when considering options to extend or terminate the lease and to purchase the underlying asset) and in assessing impairment of right-to-use assets.
Reassessment of existing or expired land easements	The Company elected not to evaluate existing or expired land easements that were not previously accounted for as leases under ASC 840, as allowed under the transition practical expedient. Going forward, new or modified land easements will be evaluated under ASU No. 2016-02.
Separation of lease and non-lease components	Lease agreements that contain both lease and non-lease components are generally accounted for separately.
Short-term lease recognition exemption	The Company also elected the short-term lease recognition exemption and will not recognize ROU assets or lease liabilities for leases with a term less than 12 months.

The new leasing standard requires recognition of leases on the consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. The Company’s future minimum based payments used to determine the Company’s lease liabilities mainly include minimum based rent payments. As most of Company’s leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

The adoption of ASC 842 had no substantial impact on the Company’s consolidated balance sheets. The most significant impact was the recognition of the operating lease right-of-use assets and the liability for operating leases. Accordingly, adoption of this standard resulted in the recognition of operating lease right-of-use assets of $8,235 and operating lease liabilities of $8,235 on the condensed consolidated balance sheet as of January 1, 2019. The adoption of ASC 842 did not result in a cumulative-effect adjustment to the opening balance of accumulated deficit.

F-11

Table of Contents

In addition, the adoption of the standard did not have a material impact on the Company’s results of operations or cash flows. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in Selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur.

Advertising Costs

Advertising costs are expensed at the time such advertising commences. Advertising expenses were $30,879 and $1,933 for the nine months ended September 30, 2019 and 2018, respectively.

Post-retirement and Post-employment Benefits

The Company’s subsidiaries in Taiwan adopted the government mandated defined contribution plan pursuant to the Taiwan Labor Pension Act (the “Act”). Such labor regulations require that the rate of contribution made by an employer to the Labor Pension Fund per month shall not be less than 6% of the worker’s monthly salaries. Pursuant to the Act, the Company makes monthly contribution equal to 6% of employees’ salaries to the employees’ pension fund. The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as incurred, were $5,424 and $5,873 for the nine months ended September 30, 2019 and 2018, respectively. Other than the above, the Company does not provide any other post-retirement or post-employment benefits.

Fair Value Measurements

FASB ASC 820, “Fair Value Measurements” defines fair value for certain financial and nonfinancial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:

	·	Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based on quoted prices in active markets that are readily and regularly available.
	·	Level 2 – Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	·	Level 3 – Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that incorporate the assumptions a market participant would use in pricing the asset or liability.

F-12

Table of Contents

The carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, inventory, advance to suppliers, prepaid expenses, accounts payable, accrued expenses, and due to shareholders, approximate fair value because of to their relatively short maturities.

Net Income (Loss) Per Share

Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents, and potentially dilutive securities outstanding during each period. For the nine months ended September 30, 2019 and 2018, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized.

Concentration of Credit Risk

Cash and cash equivalents: The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments in high quality credit institutions in Taiwan, but these investments may be in excess of the insurance limits of Taiwan Central Deposit Insurance Corporation (the “TCDIC”). The Company does not enter into financial instruments for hedging, trading or speculative purposes. Concentration of credit risk with respect to trade and notes receivables is limited due to the wide variety of customers and markets in which the Company transacts business, as well as their dispersion across many geographical areas. The Company has not experienced any losses in such accounts.

Customers: The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral.

F-13

Table of Contents

For the nine months ended September 30, 2019, one customer accounted for more than 10% of the Company’s total revenues, representing approximately 86% of its total revenues, and 80% of accounts receivable in aggregate at September 30, 2019.

Customer		Net sales for the nine months ended September 30, 2019				Accounts receivable balance as of September 30, 2019
A		$	542,499			$	1,353,215

For the nine months ended September 30, 2018, one customer, a related party, accounted for more than 10% of the Company’s total revenues, represented approximately 92% of its total revenues and 85% of accounts receivable in aggregate at September 30, 2018, respectively.

Customer		Net sales for the nine months ended September 30, 2018				Accounts receivable balance as of September 30, 2018
A		$	709,626	*		$	909,069

*Related party transactions (See Note 4).

Suppliers: The Company purchases its inventories from various suppliers.

For the nine months ended September 30, 2019, three suppliers accounted for more than 10% of the Company’s total net purchase, representing approximately 77%, 10% and 10% of total net purchase, and 0%, 0% and 71% of accounts payable in aggregate at September 30, 2019, respectively:

Supplier	Net purchase for the nine months ended September 30, 2019		Accounts payable balance as of September 30, 2019
A	$	70,868	$	-
B	$	9,106	$	-
C	$	8,825	$	2,520

For the nine months ended September 30, 2018, three suppliers accounted for more than 10% of the Company’s total net purchase, representing approximately 43%, 24% and 17% of total net purchase, and 0% of accounts payable in aggregate at September 30, 2018, respectively:

Supplier	Net purchase for the nine months ended September 30, 2018		Accounts payable balance as of September 30, 2018
D	$	51,666	$	-
A	$	28,558	$	-
E	$	20,062	$	-

Foreign-currency Transactions

Foreign-currency transactions are recorded in New Taiwan dollars (“NTD”) and Renminbi (“RMB”) at the rates of exchange in effect when the transactions occur. Gains or losses resulting from the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars and Renminbi, or when foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement. On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares of stock where such differences are accounted for as translation adjustments under stockholders’ equity.

F-14

Table of Contents

Translation Adjustment

The accounts of the Company’s subsidiaries were maintained, and their financial statements were expressed in New Taiwan Dollar (“NTD”) and Renminbi (“RMB”). Such financial statements were translated into U.S. Dollars (“$” or “USD”) in accordance ASC 830, “Foreign Currency Matters”, with the NTD and RMB as the functional currency. According to the Statement, all assets and liabilities are translated at the current exchange rate, common stock and additional paid-in capital are translated at the historical rates, and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments are reported under accumulated other comprehensive income (loss) as a component of stockholders’ equity.

Comprehensive Income (loss)

Comprehensive income (loss) includes accumulated foreign currency translation gains and losses. The Company has reported the components of comprehensive income (loss) on its consolidated statements of operations and other comprehensive income (loss).

Recent Accounting Pronouncements

The Company has implemented all new pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial statements or results of operations.

Note 2. LEASE

The Company has no finance leases. The Company’s leases primarily include office facility and copy machine under the operating lease arrangements. The Company’s operating leases have remaining lease terms of four years as of September 30, 2019.

Balance sheet information related to the Company’s leases is presented below:

	September 30, 2019
Operating Leases:
Operating lease – right of use (“ROU”) assets	$	39,226

Operating lease liability, current portion		22,351
Operating lease liability, noncurrent portion		16,876
Total operating lease liabilities	$	39,227

The following provides details of the Company’s lease expenses:

	Nine Months Ended
	September 30, 2019
Operating lease expenses, net	$	13,560
	$	13,560

F-15

Table of Contents

Other information related to leases is presented below:

	Nine Months Ended
	September 30, 2019
Cash Paid For Amounts Included In Measurement of Liabilities:
Operating cash flows from operating leases		13,560

Weighted Average Remaining Lease Term:
Operating leases	1.86 years

Weighted Average Discount Rate:
Operating leases		4	%

The minimum future annual payments under non-cancellable leases during the remainder of 2019, at rates now in force, are as follows:

	Operating leases
2019 (excluding the nine months ended September 30, 2019)	$	5,859
2020		23,435
2021		10,249
2022		831
2023		208
Total future minimum lease payments, undiscounted		40,582
Less: Imputed interest		(1,355	)
Present value of future minimum lease payments	$	39,227

Note 3. LONG-TERM INVESTMENT

On January 15, 2019, the Company, A-Best Wire Harness & Components Co., Ltd. (“A-Best” or the “Investee”), a company formed under the laws of Taiwan, and Mr. Ing-Ming Lai, a Taiwanese individual and the majority shareholder of A-Best, entered into an investment cooperation agreement (the “A-Best Investment Agreement”), pursuant to which the Company issued 10 million shares of its common stock to Mr. Ing-Ming Lai to purchase twenty percent (20%) of the issued and outstanding equity in A-Best. On May 24, 2019, the Company consummated the shareholder registration of A-Best with the Investment Commission of Ministry of Economic Affairs of Taiwan and issued 10 million shares of its common stock to Mr. Ing-Ming Lai to acquire 20% of the issued and outstanding equity in A-Best.

As of September 30, 2019, the Company owns 20% equity of A-Best. The Company holds an equity interest in A-Best accounting for its equity interest using the equity method to accounts for its equity investment as prescribed in ASC 323, Investments—Equity Method and Joint Ventures (“ASC 323”). Equity method adjustments include the Company’s proportionate share of investee’s income or loss and other adjustments required by the equity method.

F-16

Table of Contents

Summarized financial information for the Company’s equity method investee, A-Best, is as follows:

Balance Sheets (Unaudited)

	September 30,			December 31,
	2019			2018
Current Assets	$	29,818		$	20,997
Noncurrent Assets		915			-
Current Liabilities		1,279,831			1,238,711
Shareholders’ Equity (Deficit)		(1,249,098	)		(1,217,714	)

Statement of Operation (Unaudited)

	From the period from May 24, 2019 to September 30, 2019
Net Sales	$	2,827
Gross profit		713
Net income (loss)		(26,023	)
Share of profit (losses) from investment
accounted for using the equity method		(5,205	)

Note 4. RELATED PARTY TRANSACTIONS

Related party – Sales

(1)	The Company had sales to EOS Venture International Pte Ltd., (the “EOS Venture”), a Singapore company. Mr. He-Siang Yang, the officer, director, and shareholder of the Company, is the key person who can significantly affect the economic performance of EOS Venture. The sales amounted to $0 and $4,038 for nine months ended September 30, 2019 and 2018, respectively. As of September 30, 2019 and December 31, 2018, accounts receivable balance was $0 and $101,488, respectively.

(2)	The Company had sales of various products to Fortune King (HK) Trading Limited, (the “Fortune King”), a Hong Kong company. As of June 30, 2019, Fortune King was a related party of the Company because the founder and officer of Fortune King was a shareholder of the Company. On or about June 30, 2019, the founder and officer of Fortune King transferred her equity interest in the Company and therefore Fortune King is no longer a related party to the Company. The sales amounted to $542,499 and $709,626 for the nine months ended September 30, 2019 and 2018, respectively. As of September 30, 2019 and December 31, 2018, accounts receivable balance was $1,353,215 and $1,263,833, respectively.

Due to shareholders

The Company has received advances from its directors and shareholders for working capital purposes. As of September 30, 2019 and December 31, 2018, there were $153,805 and $147,281 advances outstanding, respectively. The Company and the creditors have agreed that the outstanding balances bear 0% interest rate and are due upon demand after thirty days written notice by each of the respective creditors.

Note 5. INCOME TAXES

United States

EOS, Inc. is incorporated in the United States of America and is subject to United States federal taxation. No provisions for income taxes have been made as the Company has no taxable income for the period. As of September 30, 2019, the Company had net operating loss carry forwards of $544,508 that may be available to reduce future years’ taxable income. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements as their realization is determined not likely to occur and, accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. No tax benefit has been realized since a 100 % valuation allowance has offset deferred tax asset resulting from the net operating losses.

British Virgin Islands

EOS International Inc. is incorporated in British Virgin Islands and are not required to pay income tax.

F-17

Table of Contents

Taiwan

The subsidiary of EOS Inc. and Emperor Star are incorporated in Taiwan. According to the amendments to the “Taiwan Income Tax Act” enacted by the office of the President of Taiwan on February 7, 2018, an increase in the statutory income tax rate from 17% to 20% and decrease in the undistributed earning tax from 10% to 5% are effective from January 1, 2018.

People’s Republic of China (“PRC”)

Under the Enterprise Income Tax (“EIT”) Law of the PRC, the standard EIT rate is 25%. The PRC subsidiary of the Company is subject to PRC income taxes on an entity basis on income arising in or derived from the tax jurisdiction in which they operate. No provision for income taxes have been made as Maosong had no taxable income as of and for the nine months ended September 30, 2019.

Provision for income tax consists of the following:

	For the Nine Months Ended September 30,
	2019			2018
Current income tax
U.S.	$	-		$	-
Taiwan		-			25,295
PRC		-			-
Sub total		-			25,295

Deferred income tax
U.S.
Deferred tax assets for NOL carryforwards		(2,791	)		(27,328	)
Valuation allowance		2,791			27,328
Net changes in deferred income tax (benefit)		-			-
Total income tax provision	$	-		$	25,295

The following is a reconciliation of the statutory tax rate to the effective tax rate:

	For the Nine Months Ended September 30,
	2019			2018

U.S. statutory income tax rate		21	%		21	%
Taiwan unified income tax rate		20	%		20	%
PRC standard EIT rate		25	%		N/A
Changes in valuation allowance		(66	)%		(41	)%
Other		-	%		-	%
Effective combined income tax rate		0	%		0	%

Significant components of the Company’s deferred taxes as of September 30, 2019 and December 31, 2018 were as follows:

	September 30,			December 31,
	2019			2018
Deferred tax assets:	(Unaudited)
Net operating loss carryforwards	$	114,347		$	111,556
Less: Valuation allowance		(114,347	)		(111,556	)
Deferred tax assets, net	$	-		$	-

Note 6. SUBSEQUENT EVENTS

Management has evaluated subsequent events through the date which the financial statements are available to be issued. All subsequent events requiring recognition as of September 30, 2019 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”

******

F-18

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q, including this discussion and analysis by management, contains or incorporates forward-looking statements. All statements other than statements of historical fact made in report are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words. No assurances can be given that the future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.

The following discussion and analysis should be read in conjunction with our financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

Description of Business

General Information

EOS Inc. (“we,” “us,” “our,” or the “Company”) was incorporated in the State of Nevada on April 3, 2015.

On or about November 18, 2016, the Company formed EOS INC. TAIWAN BRANCH, a Taiwanese corporation (“EITB”) and the Company owns 100% of EITB. Yu-Cheng Yang, a shareholder and director of the Company, is the sole director of EITB. Yu-Hsiang Chia is the branch manager of EITB.

Emperor Star International Trade Co., Ltd., (“Emperor Star”), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distributing various consumer products, including detergents, nutrition supplements, and skin care products.

On May 3, 2017, the Company entered into and closed a Share Purchase and Sale Agreement (the “Purchase Agreement”) with Emperor Star to acquire all issued and outstanding shares of Emperor Star in consideration of $30,562 in cash. As a result of the transaction, Emperor Star became the Company’s wholly owned subsidiary. Upon consummation of the transaction, the Company has assumed the business of Emperor Star and ceased to be a shell company. Yu-Hsiang Chia currently serves as the officer and director of Emperor Star.

On September 20, 2018, the Company set up another wholly-owned subsidiary, EOS International Inc. (“EOS(BVI)”), under the laws of British Virgin Islands. EOS(BVI) is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifying machines. On March 1, 2019, EOS(BVI) set up a wholly-owned subsidiary, Shanghai Maosong Co., Ltd (“Maosong”), under the laws of People’s Republic of China. Maosong is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifying machines in China. As of the date of this report, Maosong has a registered capital of USD $100,000, but no capital has actually been paid into Maosong.

We have never been a party to any bankruptcy, receivership or similar proceeding, nor have we undergone any material reclassification, merger, consolidation, purchase or sale of a significant amount of assets not in the ordinary course of business.

We do not own any real property. Our principal executive office is presently located at 7F.-1, No. 162, Sec. 2, Zhongshan N. Rd., Zhongshan District, Taipei City 10452, Taiwan (Republic of China). EITB and Emperor Star operate from this Taipei location. Taiwan. Emperor Star and EITB entered into the office leases which commenced on June 15, 2019 and will end on June 14, 2021. The office occupies approximately 1,388 square feet and the average amount of office rent (including the maintenance fees) is approximately $2,016 per month. Before this location, our former principal executive office was at 372 Linsen N. Road, Suite 519, Zhongshan District, Taipei City, 104, Taiwan. Our then monthly rent for that office space was $1,280 and that lease expired on June 30, 2019.

A-Best operates its business at the address of 159 Songde Road, Building 13, Room 1, Xinyi District, Taipei, Taiwan. A-Best’s lease for that office space commenced on January 20, 2018 and will end on January 19, 2020 with a term of two years. The monthly rent for that office space is $1,451, excluding utilities and maintenance fees.

Maosong rents its office at 55 Auna Road, Building 1, Suite 1316, Free Trade Zone, Shanghai, China. Maosong occupies approximately 215 square feet. The term of the lease for Maosong is three years, from January 3, 2019 to January 2, 2022, for an aggregate rental expenses of RMB 75,000 (equivalent to approximately $10,491 USD) for the entire term of the lease.

Table of Contents

General Business Overview

EOS Inc. markets and distributes a variety of consumer products selected based on its understanding of the demand for each of its products. EOS conducts its business primarily in Asia, including the People’s Republic of China (“PRC”), Taiwan, Singapore and Malaysia. The principal products that EOS markets and sells through its subsidiaries include Nine Layer Transformation Hair Cream, Deep Seawater Mineral Extract, and Lifegenes & Youthgenes. Nine Layer Transformation Hair Cream is hair-coloring product that darkens the user’s hair color to brown or black while nourishing the hair. Deep Seawater Mineral Extract is a dietary supplement that is designed to enhance the overall health and appearance of the consumer. Both Lifegenes and Youthgenes are dietary supplements designed to improve the consumer’s health. In addition to the four major products, EOS also sells and distributes other dietary supplements and skin care products from time to time as it deems profitable. During the nine months ended September 30, 2019, the net sales of dietary supplements and skin care products were $491,000, which represented approximately 78.08% of the total net sales for that period.

On April 30, 2018, we, through our Emperor Star, started purchasing a type of water purifying machines from Cosminergy Hitech Development Co., Ltd. (“Cosminergy”) and reselling the water purifying machines in certain Asian areas and countries. The sales generated from selling the water purifying machines for the year ended December 31, 2018 and nine months ended September 30, 2019 were $556,600 and $42,668, respectively, accounting for approximately 31.30% and 6.78% of the total revenue of the said period, respectively. We did not renew the Cosminergy Distribution Agreement when the said distribution agreement expired on April 30, 2019. We are actively seeking for the new vendors for this product.

In addition, we provided inventory, membership and business management software that designed by CKS Information Co., Ltd. to our customers in the fiscal year of 2018 and 2019. During the nine months ended September 30, 2019, the software business line generated $95,196 in revenue, which represented approximately 15.14% of the total net sales for that period.

Distribution Agreements and Supply Agreement

On May 1, 2015, we entered into a written Distribution Agreement with A.C. (USA), Inc. (“A.C.”) pursuant to which we have an exclusive right to market and distribute in Taiwan certain skin care products manufactured by A.C. for a period of 5 years (the “Distribution Agreement”). Pursuant to the provisions of the Distribution Agreement, we will market and promote the A.C. Products as defined therein in Taiwan. Accordingly, we are the exclusive distributor for those A.C. Products in Taiwan.

On April 30, 2018, we, through our Emperor Star, entered into a distribution agreement (the “Cosminergy Distribution Agreement”) with Cosminergy Hitech Development Co., Ltd. (Cosminergy”) pursuant to which we started purchasing a type of water purifying machines from Cosminergy and reselling the water purifying machines in certain Asian areas and countries. The Cosminergy Distribution Agreement expired on April 30, 2019 and we did not renew it.

We, through one of our wholly-owned subsidiaries, entered into a product supply agreement (“Fortune King Product Supply Agreement”) with Fortune King (HK) Trading Limited (“Fortune King”), a company formed under the laws of Hong Kong, to provide and sell any products that Fortune King orders from EOS and its subsidiaries. Pursuant to the Fortune King Product Supply Agreement, we agreed to provide products ordered by Fortune King within five business days from the order date and the products we sell should have the expiration date/shelf life at least one year from the supply date. The Fortune King Product Supply Agreement became effective on October 1, 2018 and was extended to September 30, 2021. We provide marketing information on the products we sell and training services to Fortune King. During the year ended December 31, 2018 and nine months ended September 30, 2019, the majority of EOS’ sales of Nine Layer Transformation Hair Cream, Deep Seawater Mineral Extract, Lifegenes, Youthgenes, and household water purifying machines were to Fortune King. As of June 30, 2019, Fortune King was a related party of us because the founder and officer of Fortune King was a shareholder of EOS. On or about June 30, 2019, the founder and officer of Fortune King transferred her equity interest in the Company and therefore Fortune King is no longer a related party to the Company.

Acquisition of Control Interest in A-Best

On August 7, 2019, the Company, A-Best Wire Harness & Components Co., Ltd (“A-Best”), a company formed under the laws of Taiwan, and Ing-Ming Lai, a Taiwanese individual and the majority shareholder of A-Best, entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, subject to the terms and conditions therein, the Company shall purchase thirty-one percent (31%) of the issued and outstanding equity interest in A-Best and as consideration, issue ten million (10,000,000) shares (the “Stock Consideration”) of its common stock (the “Common Stock”) to Ing-Ming Lai and pay Ing-Ming Lai fifty-five million (55,000,000) new Taiwanese dollars (“NTD”) (the “Cash Consideration”). The Company currently owns twenty percent (20%) of equity securities in A-Best, and will subsequently own a total of fifty-one percent (51%) of issued and outstanding A-Best shares when Ing-Ming Lai completes transferring his 31% of A-Best’s equity to the Company in accordance with the Purchase Agreement. Pursuant to the Purchase Agreement, the Company shall use its best efforts to obtain its shareholder approval to increase the number of authorized common stock to allow legal issuance of the Stock Consideration to Ing-Ming Lai no later than December 31, 2019. In addition, pursuant to the Purchase Agreement, the Company shall pay the Cash Consideration to Ing-Ming Lai if and only if the Company successfully completes an Initial Public Offering (the “IPO”) of its common stock, with gross proceeds of no less than $5,000,000 USD. The Purchase Agreement contains the customary confidentiality provision, representations and warranties. The Purchase Agreement also provides for mutual indemnification clauses. A-Best is a Taipei-based company that designs magnetic resonance speakers.

Table of Contents

In connection with the Purchase Agreement, on August 7, 2019, the Company, A-Best, and Ing Ming Lai entered into an Exclusive Sales Agreement (the “Exclusive Sales Agreement”), pursuant to which the Company is granted the right as the exclusive distributor to sell all of A-Best’s products, including its Micro-ceramic magnetic resonance speakers in the world, and the right to use A-Best’s trademarks and copyrights in connection with the sale of such products. The term of the Exclusive Sales Agreement shall be three (3) years from execution and be automatically renewed for another term of three (3) years unless one party gives the other parties a written notice of termination three (3) months before the end of the term.

In connection with the Purchase Agreement, on August 7, 2019, the Company and Ing-Ming Lai entered into a management agreement (the “Management Agreement”), pursuant to which the Company has agreed to maintain A-Best’s existing operations and Ing-Ming Lai’s positions as A-Best’s President and Chief Executive Officer of A-Best, until A-Best’s board of directors decides to terminate the terms of his positions. Pursuant to the Management Agreement, the Company shall also designate one individual to A-Best’s board of directors, and A-Best’s board of directors shall continue to maintain two director seats, where at least one of the two directors is designated by the Company until the Parties either reach a shareholder agreement or A-Best receives additional capital investment in equity or debt. The Management Agreement became effective upon execution. For more information about this transaction, the Purchase Agreement, the Exclusive Sales Agreement and Management Agreement, please refer to the current report on Form 8-K which was filed with the Securities and Exchange Commission on August 13, 2019.

Results of Operation - Three months ended September 30, 2019 compared to the three months ended September 30, 2018

Net sales

Net sales were $390,692 for the three months ended September 30, 2019, representing an increase of $45,432, or 13.16%, as compared to $345,260 for the three months ended September 30, 2018. The increase was primarily due to the increase in sales of skin care products and nutrition products.

Cost of sales

Cost of sales was $56,536 for the three months ended September 30, 2019, representing an increase of $13,228, or 30.54%, as compared to $43,308 for the three months ended September 30, 2018. The increase was mainly attributable to the increase in sales.

Gross profit

Gross profit was $334,156 for the three months ended September 30, 2019, compared to $301,952 for the same period in 2018. Gross profit as a percentage of net sales was 85.53% in the third quarter of 2019, compared to 87.46% in the same period in 2018. The change in gross margin was because the lower gross margin products accounted for a higher proportion of sales for the three months ended September 30, 2019.

Selling, general and administrative expenses

Selling, general and administrative expenses consist primarily of office rent, salary and related costs for personnel and facilities, and professional service fees. Selling, general and administrative expenses were $274,868 for the three months ended September 30, 2019, an increase of $167,235, or 155.38%, as compared to $107,633 for the three months ended September 30, 2018. The increase in selling, general and administrative expenses was primarily attributable to the increase in accounting, legal and professional fees of approximately $117,000 and payroll expenses of approximately $37,500 for the three months ended September 30, 2019.

Income (loss) from operations

Income (loss) from operations was $59,288 for the three months ended September 30, 2019 compared to $194,319 for the three months ended September 30, 2018, representing a decrease of $135,031, or (69.49)%. Such decrease was mainly due to the increase in selling, general and administrative expenses.

Other expense

Other expense was $710 for the three months ended September 30, 2019, a decrease of $2,559, or (78.28)%, from 3,269 for the three months ended September 30, 2018. The decrease in other expense was mainly attributable to the increase in gain on foreign currency exchange, partially offset by the increase in loss on investment in equity securities accounting for the equity method.

Net Income

As a result of the above factors, our net income was $58,578 for the three months ended September 30, 2019, as compared to our net income of $191,050 for the three months ended September 30, 2018, representing a decrease of $132,472, or (69.34)%.

Table of Contents

Results of Operation - Nine months ended September 30, 2019 compared to the nine months ended September 30, 2018

Net sales

Net sales were $628,864 for the nine months ended September 30, 2019, representing a decrease of $141,568, or 18.38%, as compared to $770,432 for the nine months ended September 30, 2018. The decrease was primarily due to the decrease in sales of water purifying machines of approximately $360,000 and skin care products of approximately $67,000, partially offset by the increase in sales of nutrition products of approximately $270,000.

Cost of sales

Cost of sales was $101,357 for the nine months ended September 30, 2019, representing an increase of $6,649 or 7.02%, as compared to $94,708 for the nine months ended September 30, 2018. Such increase was mainly due to the increase in the sales of nutrition products, partially offset by the decrease in sales of water purifying machines and nutrition products.

Gross profit

Gross profit was $527,507 for the nine months ended September 30, 2019, compared to $675,724 for the same period in 2018. Gross profit as a percentage of net sales was 83.88% for the nine months ended September 30, 2019, compared to 87.71% in the same period in 2018. The change in gross margin was because the lower gross margin product accounted for a higher proportion of sales for the nine months ended September 30, 2019.

Selling, general and administrative expenses

Selling, general and administrative expenses consist primarily of office rent, salary and related costs for personnel and facilities, and professional service fees. Selling, general and administrative expenses were $648,798 for the nine months ended September 30, 2019, representing an increase of $277,869, or 74.91%, as compared to $370,929 for the nine months ended September 30, 2018. The increase in selling, general and administrative expenses was primarily attributable to the increase in payroll expenses of approximately $145,000, accounting, legal and professional fees of approximately $36,000 and advertising expense of approximately $29,000.

Income (loss) from operations

Loss from operations was $(121,291) for the nine months ended September 30, 2019 compared to income from operations of $304,795 for the nine months ended September 30 2018, representing a decrease of $426,086, or (139.79)%. Such decrease was primarily due to the decrease in sales of water purifying machines and skincare products, and the increase in selling, general and administrative expenses.

Other income (expense)

Other income (expense) was $9,437 for the nine months ended September 30, 2019, reflecting a decrease of $18,288, or (65.96)%, compared to $27,725 for the nine months September 30, 2018. The decrease was mainly attributable to the decrease in gain on foreign currency exchange and the increase in loss on investment in equity securities accounting for the equity method.

Net Income (loss)

As a result of the above factors, our net income (loss) was $(111,854) for the nine months ended September 30, 2019, as compared to net income of $307,225 for the nine months ended September 30, 2018, representing a decrease of $419,079, or (136.41)%.

Table of Contents

Liquidity and Capital Resources

Cash and cash equivalents were $12,018 at September 30, 2019 and $36,130 at December 31, 2018. Our total current assets were $1,740,900 at September 30, 2019, as compared to $1,927,538 at December 31, 2018. Our total current liabilities were $257,497 at September 30, 2019, as compared to $299,092 at December 31, 2018.

We had working capital of $1,483,403 at September 30, 2019, compared to working capital of $1,628,446 at December 31, 2018. The decrease in working capital was primarily attributable to the decrease in cash and cash equivalents, accounts receivable and prepaid expenses and other current assets and the increase in due to shareholders, partially offset by the increase in advance to suppliers and the decrease in accounts payable.

Net cash used in operating activities was $24,000 during the nine months ended September 30, 2019, as compared to net cash provided by operating activities of $36,277 for the nine months ended September 30, 2018. The decrease in net cash provided by operating activities in the amount of $60,277 was primary attributable to the increase in net loss and the increase in due to shareholders, partially offset by the decrease in account s receivable.

Net cash used in investing activities was $933 during the nine months ended September 30, 2019, as compared to $2,890 for the nine months ended September 30, 2018. The decrease in net cash used in investing activities in the amount of $1,957 was mainly due to the decrease in purchase of equipment.

We did not have net cash flow provided by nor used in financing activities during the nine months ended September 30, 2019 and 2018.

As a result of the above factors, net decrease in cash and cash equivalents was $24,112 for the nine months ended September 30, 2019, as compared to a net increase in cash and cash equivalents of $33,235 for the nine months ended September 30, 2018.

Inflation

Our opinion is that inflation has not had a material effect on our operations and is not expected to have any material effect on our operations.

Critical Accounting Policies

Principles of Consolidation

Use of Estimates

Classification

Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.

Accounts Receivable

Inventory

Property and Equipment

Impairment of Long-Lived Assets

Long-term Equity Investment

·	Equity method investments when the Company has the ability to exercise significant influence, but not control, over the investee. Its proportionate share of the income or loss is recognized monthly and is recorded in gain (loss) on equity investments.

·	Non-marketable cost method investments when the equity method does not apply.

Table of Contents

Other-Than-Temporary Impairment

The Company’s long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:

·	Marketable equity securities include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. The Company also considers specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. The Company records other-than-temporary impairments on marketable equity securities and marketable equity method investments in gain (loss) on equity investments.

·	Non-marketable equity investments based on the Company’s assessment of the severity and duration of the impairment, and qualitative and quantitative analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory or economic environment; changes in operating structure or management of the investee; additional funding requirements; and the investee’s ability to remain in business. A series of operating losses of an investee or other factors may indicate that a decrease in value of the investment has occurred that is other than temporary and that shall be recognized even though the decrease in value is in excess of what would otherwise be recognized by application of the equity method. A loss in value of an investment that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company records other-than-temporary impairments for non-marketable cost method investments and equity method investments in gain (loss) on equity investments.

Revenue Recognition

Trade discount and allowances: The Company generally does not provide invoice discounts on product sales to its customers for prompt payment.

Product returns: The Company generally does not provide customers with the right to return a product for a full or partial refund, a credit, or an exchange for another product.

To date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products will continue to be minimal.

The following tables provide details of revenue by major products and by geography.

Table of Contents

Revenue by Major Products

For the nine months ended September 30, 2019:
Nutrition supplement	$	343,293
Skin care product		147,707
Water purifier machine		42,668
Software		95,196
Total	$	628,864

Revenue by Geography

For the nine months ended September 30, 2019:
Asia Pacific	$	628,864
Total	$	628,864

The Company applied the following practical expedients in the transition to the new standard and allowed under ASC 842:

Practical Expedient	Description
Reassessment of expired or existing contracts	The Company elected not to reassess, at the application date, whether any expired or existing contracts contained leases, the lease classification for any expired or existing leases, and the accounting for initial direct costs for any existing leases.
Use of hindsight	The Company elected to use hindsight in determining the lease term (that is, when considering options to extend or terminate the lease and to purchase the underlying asset) and in assessing impairment of right-to-use assets.
Reassessment of existing or expired land easements	The Company elected not to evaluate existing or expired land easements that were not previously accounted for as leases under ASC 840, as allowed under the transition practical expedient. Going forward, new or modified land easements will be evaluated under ASU No. 2016-02.
Separation of lease and non-lease components	Lease agreements that contain both lease and non-lease components are generally accounted for separately.
Short-term lease recognition exemption	The Company also elected the short-term lease recognition exemption and will not recognize ROU assets or lease liabilities for leases with a term less than 12 months.

Table of Contents

Advertising Costs

Advertising costs are expensed at the time such advertising commences. Advertising expenses were $30,879 and $1,933 for the nine months ended September 30, 2019 and 2018, respectively.

Post-retirement and Post-employment Benefits

Fair Value Measurements

	·	Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based on quoted prices in active markets that are readily and regularly available.
	·	Level 2 – Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	·	Level 3 – Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that incorporate the assumptions a market participant would use in pricing the asset or liability.

Table of Contents

Net Income (Loss) Per Share

Income Taxes

Concentration of Credit Risk

Customers: The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral.

Customer		Net sales for the nine months ended September 30, 2019				Accounts receivable balance as of September 30, 2019
A		$	542,499			$	1,353,215

Customer	Net sales for the nine months ended September 30, 2018			Accounts receivable balance as of September 30, 2018
A	$	709,626	*	$	909,069

__________________

*Related party transactions (See Note 4).

Suppliers: The Company purchases its inventories from various suppliers.

Table of Contents

Supplier	Net purchase for the nine months ended September 30, 2019		Accounts payable balance as of September 30, 2019
A	$	70,868	$	-
B	$	9,106	$	-
C	$	8,825	$	2,520

Supplier	Net purchase for the nine months ended September 30, 2018		Accounts payable balance as of September 30, 2018
D	$	51,666	$	-
A	$	28,558	$	-
E	$	20,062	$	-

Foreign-currency Transactions

Translation Adjustment

Comprehensive Income (loss)

Table of Contents

Recent Accounting Pronouncements

Off-Balance Sheet Arrangements

As of September 30, 2019, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As a smaller reporting company, we are not required to provide this information.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that material information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that the information is accumulated and communicated to our management, including our Chief Executive Officer and interim Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. We performed an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on their evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of September 30, 2019.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures is also based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal controls over financial reporting that occurred during our last fiscal quarter to which this Quarterly Report on Form 10-Q relates that have materially affected, or are reasonably likely to materially affect our internal controls over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

As a smaller reporting company, we are not required to provide this information.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

ITEM 6. EXHIBITS

The following exhibits are filed herewith:

Exhibit No.		Description

31.1		Certification of Chief Executive and Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.

32.1		Certification of Chief Executive and Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	EOS Inc.

Date: November 14, 2019	By:	/s/ He-Siang Yang
		He-Siang Yang
		Principal Executive Officer, Principal Financial Officer, President and Chairman of the Board

EOS (PK) (USOTC:EOSS)
Historical Stock Chart
From Mar 2024 to Apr 2024

EOS (PK) (USOTC:EOSS)
Historical Stock Chart
From Apr 2023 to Apr 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EOSS EOS Inc (PK)

Latest EOSS Messages

Loading Messages....

Eos Inc. News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EOSS EOS Inc (PK)

Latest EOSS Messages

Loading Messages....

Eos Inc. News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App